|
|
| | Raltegravir Oxalamide Impurity Basic information |
| Product Name: | Raltegravir Oxalamide Impurity | | Synonyms: | Raltegravir Impurity;Raltegravir Impurity 6;Raltegravir Oxalamide Imp;Raltegravir Oxalamide Impurity;Raltegravir Impurity 13;Deoxadiazole Oxalamide Raltegravir;Ethanediamide, N1-[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]-;Latelavir impurity 10 | | CAS: | 1193687-86-3 | | MF: | C18H20FN5O5 | | MW: | 405.38 | | EINECS: | | | Product Categories: | | | Mol File: | 1193687-86-3.mol |  |
| | Raltegravir Oxalamide Impurity Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 4.50±1.00(Predicted) | | color | White |
| | Raltegravir Oxalamide Impurity Usage And Synthesis |
| Uses | N1-[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide, is an impurity of Raltegravir Potassium (R100300), a potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. |
| | Raltegravir Oxalamide Impurity Preparation Products And Raw materials |
|